搜索临床试验以:Vorinostat, capecitabine, and cisplatin
总计5308个结果
-
ASLAN Pharmaceuticals完全的
-
Johannes Gutenberg University Mainz完全的
-
Samsung Medical Center未知
-
Thrombosis Research Institute完全的
-
Katy PetersMerck Sharp & Dohme LLC; Genentech, Inc.完全的
-
Universitätsklinikum Hamburg-EppendorfCancer Research UK; Deutsche Krebshilfe e.V., Bonn (Germany); Australasian Gastro-Intestinal Trials... 和其他合作者主动,不招人
-
Indiana University School of MedicineBayer完全的骨髓增生异常综合征 | 白血病,骨髓,急性 | 白血病,早幼粒细胞,急性美国
-
Armando Santoro, MD终止
-
Groupe Francophone des MyelodysplasiesMerck Sharp & Dohme LLC终止
-
The Methodist Hospital Research Institute撤销
-
Washington University School of Medicine终止
-
Allarity Therapeutics完全的
-
The Christie NHS Foundation TrustUniversity College London Hospitals; University College, London; Royal Free Hospital NHS Foundation...尚未招聘
-
Fox Chase Cancer CenterNational Comprehensive Cancer Network完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的淋巴瘤 | 白血病 | 小肠癌 | 前列腺癌 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤美国
-
National Center for Tumor Diseases, HeidelbergMerck Sharp & Dohme LLC; University Hospital Heidelberg完全的
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon完全的
-
University Health Network, Toronto完全的
-
Steven E. CoutreMerck Sharp & Dohme LLC完全的Acute Myeloid Leukemia With 11q23-abnormality in Relapse美国
-
Merck Sharp & Dohme LLC完全的
-
Imugene Limited主动,不招人
-
Royal Marsden NHS Foundation Trust完全的
-
The Netherlands Cancer InstituteKarolinska Institutet; UMC Utrecht; Maastricht Radiation Oncology; The Christie NHS Foundation Trust 和其他合作者主动,不招人
-
University of Virginia完全的
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLC完全的
-
University of OxfordMerck KGaA, Darmstadt, Germany完全的
-
Bristol-Myers SquibbExelixis完全的